Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stages II-III Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01050075
What this trial is testing

Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+3 more
City of Hope Medical Center 7
Not applicableLooking for participantsNCT06905301
What this trial is testing

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT07460752
What this trial is testing

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
Mayo Clinic 98
Large-scale testing (Phase 3)Active Not RecruitingNCT02445391
What this trial is testing

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+9 more
ECOG-ACRIN Cancer Research Group 415
Testing effectiveness (Phase 2)Looking for participantsNCT07191717
What this trial is testing

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00002679
What this trial is testing

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Who this might be right for
Breast Cancer
Yale University 89
Not applicableLooking for participantsNCT06930859
What this trial is testing

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 2,766
Testing effectiveness (Phase 2)Ended earlyNCT02096588
What this trial is testing

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Not applicableStudy completedNCT00090974
What this trial is testing

Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Testing effectiveness (Phase 2)Study completedNCT02593175
What this trial is testing

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+8 more
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT04329065
What this trial is testing

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
University of Washington 25
Large-scale testing (Phase 3)Study completedNCT00775645
What this trial is testing

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityFatigue+2 more
SWOG Cancer Research Network 437
Very early researchStudy completedNCT03407716
What this trial is testing

Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

Who this might be right for
Cancer SurvivorStage I Breast Cancer AJCC v7Stage I Colon Cancer AJCC v6 and v7+17 more
Mayo Clinic 2
Testing effectiveness (Phase 2)Study completedNCT01070706
What this trial is testing

Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib

Who this might be right for
Breast Cancer
Jungsil Ro 15
Early research (Phase 1)WithdrawnNCT04205071
What this trial is testing

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+21 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03106415
What this trial is testing

Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaMetastatic Triple-Negative Breast CarcinomaStage III Breast Cancer AJCC v7+4 more
Mayo Clinic 23
Large-scale testing (Phase 3)UnknownNCT00002851
What this trial is testing

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 4,000
Next Page